Now Playing
|Videos|August 19, 2016
Goals of AIM at Melanoma
Advertisement
Episodes in this series
Advertisement
Related to this article
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
A custom mRNA vaccine is the first to succeed in a phase 3 trial. Learn how personalized cancer vaccines work and what to watch for at ESMO 2026.
Advertisement
Advertisement
Trending on CURE
1
Diagnosed With Sarcoma at 21, She Found Her People at Mary's Place
2
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
New Mom With Stage 4 Breast Cancer Finds Hope in a Second Opinion
5